Scynexis CFO granted 100K options at $4.91
SCYNEXIS granted its CFO 100,000 stock options at a $4.91 strike price, vesting over four years subject to continued service.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
SCYNEXIS INC (SCYX) reported that its Chief Financial Officer, Sanjay Subramanian, received a grant of stock options on September 9, 2026 to purchase 100,000 shares of common stock at an exercise price of $4.91 per share. These options expire on September 8, 2036 and vest 25% after one year, with the remainder vesting in equal monthly installments over the following 36 months, contingent on continued service.
Insider Trade Summary
Grant/Award: 100,000 shares
Grant/Award
1 txn
Insider
Subramanian Sanjay
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 100,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 100,000 contracts (Direct)
Footnotes (1)
- F1. 25% of the shares subject to this option vests on the one-year anniversary of the grant date with the remainder vesting in equal monthly installments for thirty-six (36) months thereafter, provided the Reporting Person continues to provide continuous services to the Issuer.
Key Figures
Options granted: 100,000 options
Exercise price: $4.91 per share
Underlying shares: 100,000 shares
+4 more
7 metrics
Options granted
100,000 options
Stock option grant to CFO on September 9, 2026
Exercise price
$4.91 per share
Conversion or exercise price of the stock options
Underlying shares
100,000 shares
Common stock underlying the option grant
Options after transaction
100,000 options
Total stock options held from this award following the grant
Vesting cliff
25% after 1 year
Portion of options vesting on the one-year anniversary of grant
Remaining vesting period
36 months monthly
Remainder of options vesting in equal monthly installments
Expiration date
September 8, 2036
Option term end date
Key Terms
Stock Option (Right to Buy), exercise price, vesting, grant date, +1 more
5 terms
Stock Option (Right to Buy) financial
"The security title is listed as Stock Option (Right to Buy)."
exercise price financial
"The options have a conversion or exercise price of $4.91 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"25% of the shares subject to this option vests on the one-year anniversary."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
grant date financial
"25% vests on the one-year anniversary of the grant date."
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
expiration date financial
"The options have an expiration date of September 8, 2036."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did SCYX report for its CFO?
SCYNEXIS reported that its Chief Financial Officer, Sanjay Subramanian, received a grant of stock options for 100,000 shares of common stock on September 9, 2026, as a compensation-related award rather than a market purchase.
What is the exercise price of the CFO’s new SCYX stock options?
The stock options granted to the SCYNEXIS CFO have an exercise price of $4.91 per share for the underlying common stock, as specified in the derivative security terms.
What is the vesting schedule for the SCYX CFO’s stock options?
According to the footnote, 25% of the options vest on the one-year anniversary of the grant date, with the remaining 75% vesting in equal monthly installments over 36 months, provided the CFO continues to provide continuous services to SCYNEXIS.
When do the SCYX CFO’s newly granted stock options expire?
The stock options granted to the SCYNEXIS CFO expire on September 8, 2036, giving a 10-year term from around the grant date before they can no longer be exercised.
Was the SCYX CFO’s option grant reported under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is unchecked, and there is no footnote indicating that the CFO’s stock option grant was made pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
